This editorial reviews evidence on admission eosinopenia (≤10 cells/μL) as a predictor of outcomes in hospitalized patients with community-acquired pneumonia (CAP), commenting on a linked multicenter prospective study (Weckler et al, CAPNETZ cohort) and synthesizing findings from related studies.
Admission eosinopenia (≤10 cells/μL) was independently associated with ICU admission, need for mechanical ventilation, and longer hospital stay in CAP; it did not predict 30-day mortality in the general CAP cohort (overall mortality ~9%), but in severe CAP (ICU-admitted patients, n=496), eosinopenia (≤50 cells/μL) was an independent predictor of 30-day death (HR 1.95; 95% CI 1.19–3.20; P=.0008). Combined eosinopenia and lymphopenia showed additive predictive value for resource utilization.
This is an editorial, not a primary study — conclusions are synthesized from multiple studies with differing eosinopenia thresholds (≤10 vs ≤50 cells/μL), making direct comparisons difficult. The relatively low overall mortality in the CAPNETZ cohort (~9%) may limit detection of a mortality signal. Authors call for prospective multicenter trials to confirm these findings.
Check a simple blood count eosinophil level at admission in CAP patients — eosinopenia (≤10 cells/μL) flags higher risk of ICU admission and mechanical ventilation and can guide resource planning. Rising eosinophil counts during recovery may signal clinical improvement, consistent with the concept of 'dawn of well-being.'
Explore related topics
